Does retatrutide burn fat?

It produced large mean weight loss in trials, which is not the same sentence as burns fat as a measured fat-oxidation result in a person. TRIUMPH-1 randomized 2,339 people and a company release reported up to 28.3% mean weight loss at 80 weeks on 12 milligrams versus 2.2% on placebo. Phase 2 ran 48 weeks in 338 adults, up to 24.2% at 12 milligrams. A Phase 2a liver-fat substudy found 86% on 12 milligrams reached liver fat below 5% at 24 weeks versus 0% on placebo. The added glucagon receptor activity is proposed to raise energy expenditure and hepatic fat oxidation. That is a mechanism hypothesis plus weight and liver-fat averages, not a counted fat-burn rate for an individual. Retatrutide remains investigational. A research-chemical vial is not the trial product. This FAQ does not invent a fat-oxidation percentage. Full record at /compounds/retatrutide.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of glp-1 and metabolic peptides. Semaglutide, tirzepatide, retatrutide, and the rest of the incretin and glucagon receptor family.